共 342 条
[1]
Ference BA(2017)Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel Eur. Heart J. 38 2459-2472
[2]
Ginsberg HN(2012)The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials Lancet 380 581590-2567
[3]
Graham I(2019)The Association between low-density lipoprotein cholesterol and incident atherosclerotic cardiovascular disease in older adults: results from the national institutes of health pooled cohorts J. Am. Geriatr. Soc. 67 2560-1297
[4]
Ray KK(2016)Association between lowering LDL-C and cardiovascular risk reduction among different therapeutic interventions: a systematic review and meta-analysis Jama 316 1289-489
[5]
Packard CJ(2016)A review of low-density lipoprotein cholesterol, treatment strategies, and its impact on cardiovascular disease morbidity and mortality J. Clin. Lipidol. 10 472-953
[6]
Bruckert E(2016)Chinese guidelines on prevention and treatment of dyslipidemia in adults(2016 revison) Chin. Circ. J. 31 937-60
[7]
Hegele RA(2014)An International Atherosclerosis Society Position Paper: global recommendations for the management of dyslipidemia—full report J. Clin. Lipidol. 8 29-488
[8]
Krauss RM(2014)National Lipid Association recommendations for patient-centered management of dyslipidemia: part 1—executive summary J. Clin. Lipidol. 8 473-188
[9]
Raal FJ(2020)2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk Eur. Heart J. 41 111-S45
[10]
Schunkert H(2014)2013 ACC/AHA Guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults Circulation 129 S1-244